Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.580
-0.120 (-7.06%)
At close: Mar 28, 2025, 4:00 PM
1.616
+0.036 (2.27%)
After-hours: Mar 28, 2025, 7:56 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $23.59 million as of March 28, 2025. Its market cap has increased by 99.15% in one year.
Market Cap
23.59M
Enterprise Value
5.80M
1-Year Change
99.15%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $23.59M, a decrease of -86.33%. That is a compound annual growth rate of -38.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 23.59M | -8.11% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |